Bioforce Nanosciences Holdings (BFNH) Receivables (2018 - 2019)
Bioforce Nanosciences Holdings (BFNH) recorded quarterly Receivables of $5962.0 in Q3 2019, little changed on a QoQ basis from $5962.0 in Q2 2019, and up 8.16% YoY from $5512.0 in Q3 2018.
Powered by 
Analysis
Bioforce Nanosciences Holdings (BFNH) Receivables (2018 - 2019) Analysis & Trends
Bioforce Nanosciences Holdings (BFNH) has reported Receivables for 2 consecutive years, with $5962.0 the latest figure, recorded in Q3 2019.
- For the quarter ending Q3 2019, Receivables rose 8.16% year-over-year to $5962.0; the trailing twelve-month figure through Sep 2019 stood at $5962.0 (up 8.16% YoY), and the FY2018 full-year result was $5735.0, changed N/A from the prior year.
- Receivables was $5962.0 for Q3 2019 at Bioforce Nanosciences Holdings, roughly flat from $5962.0 in the prior quarter.
- The five-year high for Receivables was $5962.0 in Q2 2019, with the low at $5512.0 in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.76 Bn | 69.72 Bn | 3.30 Bn | 1.96 Bn |
| 2 | Kenvue | 35.95 Bn | 34.84 Bn | 2.30 Bn | 2.48 Bn |
| 3 | Kimberly Clark | 34.91 Bn | 34.08 Bn | 1.60 Bn | 1.86 Bn |
| 4 | Bath & Body Works | 3.94 Bn | 3.15 Bn | 692.00 Mn | 154.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.94 Bn | 2.87 Bn | - | 191.92 Mn |
| 6 | Perrigo | 2.07 Bn | 1.67 Bn | 313.90 Mn | 709.90 Mn |
| 7 | Edgewell Personal Care | 1.33 Bn | 933.73 Mn | 242.50 Mn | 119.40 Mn |
| 8 | Herbalife | 1.30 Bn | 935.57 Mn | 1.03 Bn | 115.90 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | 100,335.00 |
| 10 | Bioforce Nanosciences Holdings | 206.66 Mn | 206.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 5,962.00 |
| Jun 30, 2019 | 5,962.00 |
| Mar 31, 2019 | 5,850.00 |
| Dec 31, 2018 | 5,735.00 |
| Sep 30, 2018 | 5,512.00 |